NEW YORK (Reuters Health) - New research indicates that drinking coffee lowers the risk of developing cancer of the oral cavity or throat, at least in the general population of Japan.

LONDON (Reuters) - Dutch researchers have built a three-dimensional model of a type of virus that causes SARS in a step that could one day help in the battle against the deadly disease.

BOSTON (Reuters) - Merck's popular osteoporosis drug Fosamax and other similar drugs may carry a risk for esophageal cancer, a U.S. Food and Drug Administration official said on Wednesday.

NEW YORK (Reuters Health) - Surgery to remove the esophagus is not being used as often as it should be for some cases of early-stage cancer of the esophagus.

NEW YORK (Reuters Health) - The largest prostate cancer screening program in the history of the United States is showing high compliance and consistent results, researchers report.

NEW YORK (Reuters Health) - The prevalence of allergies among children with chronic constipation is not significantly different from that of the general population -- and an allergy to cow's milk does not seem to be involved, researchers report in the Archives of Disease in Childhood.

NEW YORK (Reuters Health) - In the large Women's Antioxidant Cardiovascular Study, participants who took beta carotene, vitamin C, vitamin E, or a combination of supplements had no significant reductions in their risk of cancer.

NEW YORK (Reuters Health) - Among premenopausal women taking steroids for lupus, various treatments preserve bone mineral density and "should be considered" for preventing the bone-thinning disease osteoporosis, advise researchers in a report published this month.

NEW YORK (Reuters Health) - Young people with type 1 and type 2 diabetes are often overweight and many turn to unhealthy weight loss practices, such as using over-the-counter diet aids without a doctor's advice, fasting and taking laxatives, new research shows.

NEW YORK (Reuters Health) - Use of a non-steroidal anti-inflammatory drug (NSAID) for over 5 years may lessen a person's risk of developing cancer of the lower portion of the large bowel, study findings suggest.

NEW YORK (Reuters Health) - The odds are high that a woman who is prescribed an "anticholinergic" drug to relieve urinary incontinence or other lower urinary tract symptom will discontinue the medication not long after starting it, a study suggests. This is true regardless of the class of medication used.

NEW YORK (Reuters Health) - An enlarged prostate due to benign prostatic hyperplasia, or BPH, can be safely and effectively removed using a type of minimally invasive single-keyhole surgery, researchers report.

NEW YORK (Reuters Health) - A pilot study of routine versus restrictive use of episiotomy during operative vaginal delivery has not provided conclusive evidence for the superiority of either approach, Irish and UK researchers report.

WASHINGTON (Reuters) - A one-time set of steroid injections for pregnant women at high risk of giving birth prematurely can head off major problems for the baby, but more injections give no further benefit, Canadian researchers said.

WASHINGTON (Reuters) - A one-time set of steroid injections for pregnant women at high risk of giving birth prematurely can head off major problems for the baby, but more injections give no further benefit, Canadian researchers said.

NEW YORK (Reuters Health) - A simplified colorectal cancer screening test that detects tumor DNA in stool is an improvement over an earlier-generation assay, according to North American researchers.

NEW YORK (Reuters Health) - Stomach acid reflux or heartburn may be a particular problem for people with breathing problems such as emphysema or bronchitis, known generally as chronic obstructive pulmonary disease or COPD, researchers report.

NEW YORK (Reuters Health) - Cigarette smoking is associated with the occurrence of colorectal cancer and with mortality from the disease, according to a multinational team.

NEW YORK (Reuters Health) - Screening for colorectal cancer by colonoscopy seems to prevent about two-thirds of deaths from colon cancer, rather than 90 percent as has been widely claimed, a study indicates.

GAITHERSBURG, Md. (Reuters) - ImClone Systems and Amgen Inc told a U.S. advisory panel on Tuesday they have enough data from earlier studies to show their colon cancer drugs help those with a normal version of a certain gene.